AU2670897A - Fibulin pharmaceutical compositions and related methods - Google Patents
Fibulin pharmaceutical compositions and related methodsInfo
- Publication number
- AU2670897A AU2670897A AU26708/97A AU2670897A AU2670897A AU 2670897 A AU2670897 A AU 2670897A AU 26708/97 A AU26708/97 A AU 26708/97A AU 2670897 A AU2670897 A AU 2670897A AU 2670897 A AU2670897 A AU 2670897A
- Authority
- AU
- Australia
- Prior art keywords
- fibulin
- pharmaceutical compositions
- related methods
- methods
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000006482 fibulin Human genes 0.000 title 1
- 108010044392 fibulin Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62763696A | 1996-04-04 | 1996-04-04 | |
US08627636 | 1996-04-04 | ||
PCT/US1997/006280 WO1997038014A1 (en) | 1996-04-04 | 1997-04-03 | Fibulin pharmaceutical compositions and related methods |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2670897A true AU2670897A (en) | 1997-10-29 |
Family
ID=24515462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU26708/97A Abandoned AU2670897A (en) | 1996-04-04 | 1997-04-03 | Fibulin pharmaceutical compositions and related methods |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2670897A (en) |
WO (1) | WO1997038014A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6001968A (en) | 1994-08-17 | 1999-12-14 | The Rockefeller University | OB polypeptides, modified forms and compositions |
CA2337667C (en) * | 1998-08-10 | 2008-04-29 | Amgen Inc. | Dextran-leptin conjugates, pharmaceutical compositions and related methods |
US6420339B1 (en) | 1998-10-14 | 2002-07-16 | Amgen Inc. | Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
US8106098B2 (en) | 1999-08-09 | 2012-01-31 | The General Hospital Corporation | Protein conjugates with a water-soluble biocompatible, biodegradable polymer |
WO2001089548A2 (en) * | 2000-05-24 | 2001-11-29 | Schering Aktiengesellschaft | Pharmaceutical use of fibulin-1 |
CA2441006A1 (en) * | 2001-03-08 | 2002-09-19 | Hyseq, Inc. | Methods and materials relating to fibulin-like polypeptides and polynucleotides |
PT2219031E (en) | 2001-10-22 | 2013-05-17 | Amgen Inc | Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment |
US8394765B2 (en) | 2004-11-01 | 2013-03-12 | Amylin Pharmaceuticals Llc | Methods of treating obesity with two different anti-obesity agents |
KR101123549B1 (en) | 2004-11-01 | 2012-04-18 | 아밀린 파마슈티칼스, 인크. | Treatment of obesity and related disorders |
US20110028408A1 (en) * | 2007-10-31 | 2011-02-03 | Crc For Asthma And Airways Ltd | diagnostic molecule and therapeutic target |
WO2009149379A2 (en) | 2008-06-05 | 2009-12-10 | Regents Of The University Of Michigan | Use of leptin for the treatment of fatty liver diseases and conditions |
DK2621519T3 (en) | 2010-09-28 | 2017-10-16 | Aegerion Pharmaceuticals Inc | Leptin-ABD fusion polypeptides with improved duration of action |
EP4082541A1 (en) | 2012-09-27 | 2022-11-02 | The Children's Medical Center Corporation | Compounds for the treatment of obesity and methods of use thereof |
ES2709976T3 (en) | 2013-11-26 | 2019-04-22 | Childrens Medical Ct Corp | Compounds for the treatment of obesity and procedures for their use |
US20170209408A1 (en) | 2014-04-03 | 2017-07-27 | The Children's Medical Center Corporation | Hsp90 inhibitors for the treatment of obesity and methods of use thereof |
FI3509624T3 (en) | 2016-09-12 | 2023-10-18 | Amryt Pharmaceuticals Inc | Methods of detecting anti-leptin neutralizing antibodies |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991002755A1 (en) * | 1989-08-18 | 1991-03-07 | La Jolla Cancer Research Foundation | Fibulin |
-
1997
- 1997-04-03 AU AU26708/97A patent/AU2670897A/en not_active Abandoned
- 1997-04-03 WO PCT/US1997/006280 patent/WO1997038014A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1997038014A1 (en) | 1997-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3767097A (en) | Shampoo compositions and method | |
AU5081298A (en) | Surgical method and composition therefor | |
AU3641597A (en) | Methods and compositions comprising r-ibuprofen | |
AU3049397A (en) | Cyclosporin-containing pharmaceutical composition | |
AU4479897A (en) | Compositions including r-nsaids and therapeutic and prophylactic methods employing said compositions | |
AU4762797A (en) | Pharmaceutical compositions | |
AU2825597A (en) | Elastomer compositions and methods | |
AU2075997A (en) | Orally-administered interferon-tau compositions and methods | |
AU2967597A (en) | Pharmaceutical compositions | |
HUP9900424A2 (en) | Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them | |
AU5856898A (en) | Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them | |
AU2972597A (en) | Compositions and uses thereof | |
AU2349399A (en) | R-lansoprazole compositions and methods | |
AU1731997A (en) | Antipathogenic peptides and compositions comprising them | |
AU2670897A (en) | Fibulin pharmaceutical compositions and related methods | |
AU5565099A (en) | Pharmaceutical compositions and methods for use | |
AU3777897A (en) | Pharmaceutical compositions | |
AU4083997A (en) | Gata-6 transcription factor: compositions and methods | |
AU3304097A (en) | Water-based makeup compositions and methods for their preparation | |
AU4876397A (en) | Insecticidal compositions and methods | |
HUP0000460A3 (en) | Imidazopyridazines and pharmaceutical compositions thereof | |
AU3200197A (en) | New composition and methods | |
AU3460897A (en) | Medicinal compositions | |
AU5125698A (en) | Stabilized pharmaceutical compositions based on quinupristine and on dalfopristine and their preparation | |
AU3354797A (en) | Novel anticoagulant glycosides and pharmaceutical compositions thereof |